Vaccines, Blood & Biologics
?
-
Vaccines Research
-
Bacterial Polysaccharides
Characterization of Bacterial Glycoconjugates and Development of Associated Vaccine Technologies
Wille Vann, PhDEvaluating the Host and Microbial Factors That Impact the Efficacy of Polysaccharide Vaccines
Mustafa Akkoyunlu, MD, PhDBiomarkers of Vaccine Safety and Effectiveness for Encapsulated Bacterial Pathogens
Margaret C. Bash, MD, MPHStudying the Structure of Carbohydrates in Order to Better Understand Bacterial Vaccines and Pathogens
John F. CipolloImprovement of Biological Product Quality by Application of New Technologies to Characterize of Vaccines and Blood Products: NMR Spectroscopy and Light Scattering
Daron Freedberg, PhDBacterial Vaccine Safety: Identify Genetic Determinants of Disease in Moraxella Catarrhalis
Wei Wang, PhD
-
-
Enteric & Sexually Transmitted Diseases
Disease-causing Gut Bacteria: Improving Vaccine Safety and Efficacy of Combination Vaccines to Protect Against Diarrheal Diseases and Select Agents
Dennis Kopecko, PhDBacterial Vaccine Safety: Biomarkers of Virulence and Attenuation in Bordetella Pertussis (Whooping Cough) and Anthrax Bacteria
Scott Stibitz, PhD
-
-
Mycobacterial Diseases & Cellular Immunology
Evaluation of the Safety and Effectiveness of TB Vaccines, Including DNA-Based, Viral Vectored and Live-Attenuated Products
Sheldon Morris, PhDSafety and Efficacy of Vaccines Against Intracellular Pathogens: Looking for Signs that Vaccines for Tuberculosis and Other Intracellular Pathogens Will Be Effective
Siobhan C. Cowley, PhDNew Ways to Predict How Well Vaccines Protect Against Tuberculosis, Tularemia and Other Bacteria That Live Inside Cells
Karen Elkins, PhD
-
-
Respiratory & Special Pathogens
Improving Vaccine Manufacturing Evaluation for Bacterial Respiratory Pathogens
Drusilla Burns, PhDDevelopment, Evaluation and Improvement of Quality Control Methods for Bacterial Vaccines
Juan L. Arciniega, PhDDeveloping Test Methods to Measure the Potency of Toxoid Vaccine(s) and Antitoxin(s) Against Botulism, Diphtheria and Tetanus
James Keller, PhDDeveloping and Evaluating Animal Models for Studying the Safety and Efficacy of Vaccines Against Anthrax, Staphylococcal Infections, and Pertussis
Todd Merkel, PhDPlague Vaccine Efficacy: Development of New Assays to Better Assess Vaccine Efficacy
Karen Meysick, PhDBiomarkers of Vaccine Safety and Efficacy for Diphtheria Vaccines
Michael Schmitt, PhD
-
-
DNA & Hepatitus Viruses
Development of Quantitative Assays to Evaluate the Safety of Cell Substrates and Vaccines
Keith Peden, PhDHepatitis C Vaccines: Developing Ways to Grow the Virus in the Laboratory and Evaluate Vaccines that Prevent Infection
Stephen Feinstone, MDDevelopment of Assays of Defined Sensitivity for the Regulatory Management of Novel Cell Substrates
Andrew Lewis, MDVaccine Safety: Virus Detection and Latency
Philip Krause, MDDeveloping New Methods to Measure the Efficacy, Safety and Potency of Preventive and Therapeutic Vaccines Against Hepatitis Viruses
Marian Major, PhDDNA Virus Vaccines and Vectors
Jerry Weir, PhD
-
-
Methods Development
Evaluation of Safety and Potency of Viral Vaccines Based on Analysis of Molecular Consistency
Konstantin M. Chumakov, PhDNew Ways to Improve Testing of Vaccines for Purity and Safety
Vladimir Chizhikov, PhDDetermining the Safety and Efficacy of Vaccines to Protect Against Viruses that Infect the Central Nervous System
Steven Rubin, MD
-
-
Pediatric & Respiratory Viral Diseases
Facilitating Influenza Virus Vaccine Production by Optimizing Vaccine Strains
Zhiping Ye, MD, PhDDeveloping Tests to Detect Evidence of Protective Immune Responses Generated by Vaccines for Respiratory Viruses That Infect Infants, Children and the Elderly.
Judy Beeler, MDHelping to Develop Better Influenza Vaccines
Maryna Eichelberger, PhD
-
-
Retrovirus Research
-
-
Vector Borne Viral Diseases
-
-
Immunology
Evaluating New Approaches to Developing AIDS Vaccines by Creating Virus-like Particles that Display HIV Antigens or by Using Live, Attenuated (Weakened), non-HIV Viruses to Express HIV Proteins
Ira Berkower, MDEvaluating Viral Antigens and Antibody Neutralization for HIV/AIDS, Smallpox, and Influenza
Carol Weiss, MD
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-